Evolution of the NCI antibody-drug conjugate portfolio: from chemical engineering to clinical complexity
This story is reported by Frontiers. Read what other outlets are saying below, then open the original report for full details.
This story is reported by Frontiers. Read what other outlets are saying below, then open the original report for full details.